CRISPR Helps Decode the Epigenetic Mysteries of...
Sep. 25, 2023
Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
iECURE
Main focus: Treatment of genetic diseases using in vivo gene editing
Company stage: Pre-clinical
Diseases (gene editing): Liver diseases, other genetic diseases
Genome editing tool: ARCUS Meganuclease
Funding stage: Private
Location: Philidelphia, PA, USA
Website: https://iecure.com/
Gene editing partnerships: Precision Biosciences
iECURE develops novel medicines to treat liver diseases and other genetic diseases. The company has licensed Precision Biosciences' ARCUS Meganuclease gene-editing technology for the development of treatments targeting the PCSK9 gene as well as other targets.
